Abvc Biopharma (ABVC) Current Taxes (2023 - 2026)

Abvc Biopharma's (ABVC) quarterly Current Taxes came in at $5888.0 in Q1 2026, down 50.79% on a QoQ basis from $11964.0 in Q4 2025.

Abvc Biopharma (ABVC) Current Taxes (2023 - 2026) Analysis & Trends

Abvc Biopharma (ABVC) has 4 years of Current Taxes data on file, last reported at $5888.0 in Q1 2026.

Quarterly Current Taxes changed N/A year-over-year to $5888.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5888.0 (changed N/A YoY) and the FY2025 annual result came in at $11964.0, changed N/A from the prior year.
Current Taxes eased to $5888.0 in Q1 2026, from $11964.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $112946.0 in Q4 2023 to a low of $5888.0 in Q1 2026.
A 4-year average of $44766.5 and a median of $17742.5 in 2025 frame the typical range for Current Taxes.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	139.35 Bn	131.49 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.24 Bn	78.25 Bn	3.93 Bn	-
3	Argenx Se	65.26 Bn	60.08 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.83 Bn	53.69 Bn	52.00 Mn	-
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.68 Bn	28.37 Bn	992.69 Mn	-
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.50 Bn	26.34 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.44 Bn	-	-
10	Abvc Biopharma	22.82 Mn	22.82 Mn	-	-

Download Data